PT1157019E - 4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2 - Google Patents
4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2Info
- Publication number
- PT1157019E PT1157019E PT99963422T PT99963422T PT1157019E PT 1157019 E PT1157019 E PT 1157019E PT 99963422 T PT99963422 T PT 99963422T PT 99963422 T PT99963422 T PT 99963422T PT 1157019 E PT1157019 E PT 1157019E
- Authority
- PT
- Portugal
- Prior art keywords
- oxindoles
- cyclin
- alkynyl
- alkenyl
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11259198P | 1998-12-17 | 1998-12-17 | |
US14907399P | 1999-08-16 | 1999-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1157019E true PT1157019E (pt) | 2003-06-30 |
Family
ID=26810131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99963422T PT1157019E (pt) | 1998-12-17 | 1999-12-08 | 4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2 |
Country Status (20)
Country | Link |
---|---|
US (3) | US6130239A (pt) |
EP (1) | EP1157019B1 (pt) |
JP (1) | JP2002532492A (pt) |
KR (1) | KR100649925B1 (pt) |
CN (1) | CN1138773C (pt) |
AR (1) | AR024847A1 (pt) |
AT (1) | ATE234830T1 (pt) |
AU (1) | AU770375B2 (pt) |
BR (1) | BR9916327A (pt) |
CA (1) | CA2354873A1 (pt) |
CO (1) | CO5261600A1 (pt) |
DE (1) | DE69906152T2 (pt) |
DK (1) | DK1157019T3 (pt) |
ES (1) | ES2192877T3 (pt) |
PE (1) | PE20001537A1 (pt) |
PT (1) | PT1157019E (pt) |
TR (1) | TR200101860T2 (pt) |
TW (1) | TW550262B (pt) |
UY (1) | UY25857A1 (pt) |
WO (1) | WO2000035908A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569868B2 (en) | 1998-04-16 | 2003-05-27 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
CN1138773C (zh) * | 1998-12-17 | 2004-02-18 | 霍夫曼-拉罗奇有限公司 | 4-链烯基(和炔基)氧吲哚作为细胞周期蛋白-依赖性激酶尤其是cdk2的抑制剂 |
ES2367007T3 (es) * | 1999-11-24 | 2011-10-27 | Sugen, Inc. | Derivados de indolinona ionizables y su uso como ligandos de ptk. |
US6878733B1 (en) | 1999-11-24 | 2005-04-12 | Sugen, Inc. | Formulations for pharmaceutical agents ionizable as free acids or free bases |
AU784266B2 (en) * | 1999-12-22 | 2006-03-02 | Sugen, Inc. | Indolinone derivatives for modulation of c-kit tyrosine kinase |
EP1255752B1 (en) * | 2000-02-15 | 2007-08-08 | Sugen, Inc. | Pyrrole substituted 2-indolinone protein kinase inhibitors |
EP1272483A2 (en) * | 2000-03-24 | 2003-01-08 | Millenium Pharmaceuticals, Inc. | OXINDOLE INHIBITORS OF FACTOR Xa |
MY128449A (en) | 2000-05-24 | 2007-02-28 | Sugen Inc | Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
US6706709B2 (en) | 2000-06-02 | 2004-03-16 | Sugen, Inc. | Indolinone derivatives as protein kinase/phosphatase inhibitors |
JP2004502686A (ja) | 2000-06-30 | 2004-01-29 | スージェン・インコーポレーテッド | 4−ヘテロアリール−3−ヘテロアリーリデニル−2−インドリノンおよび蛋白質キナーゼ阻害剤としてのその使用 |
PE20020776A1 (es) * | 2000-12-20 | 2002-08-22 | Sugen Inc | Indolinonas 4-aril sustituidas |
US6504034B2 (en) * | 2001-01-23 | 2003-01-07 | Hoffmann-La Roche Inc. | Naphthostyrils |
AR042586A1 (es) * | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
FR2822155B1 (fr) | 2001-03-13 | 2003-12-12 | Aventis Pharma Sa | Composes derives des oxindoles et leur application therapeutique en cancerologie |
AU2002324684B2 (en) * | 2001-08-15 | 2006-10-05 | Pharmacia And Upjohn Company Llc | Crystals including a malic acid salt of N-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3H-indole-3-ylidene) methyl]-2, 4-dimethyl-1H-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
EP1434774A1 (en) | 2001-10-10 | 2004-07-07 | Sugen, Inc. | 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
CA2470480C (en) * | 2001-12-27 | 2010-12-14 | Theravance, Inc. | Indolinone derivatives useful as protein kinase inhibitors |
FR2948940B1 (fr) * | 2009-08-04 | 2011-07-22 | Servier Lab | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US20140205537A1 (en) * | 2011-06-24 | 2014-07-24 | Zenobia Therapeutics, Inc. | Lrrk2 inhibitors |
CN106187904B (zh) * | 2015-05-25 | 2021-07-06 | 中国医学科学院药物研究所 | 含丙炔酰胺基的2-苯基咪唑类衍生物及其制法和药物组合物与用途 |
AU2018333913B2 (en) | 2017-09-14 | 2022-11-17 | Daiichi Sankyo Company, Limited | Compound having cyclic structure |
WO2022113003A1 (en) | 2020-11-27 | 2022-06-02 | Rhizen Pharmaceuticals Ag | Cdk inhibitors |
WO2022149057A1 (en) | 2021-01-05 | 2022-07-14 | Rhizen Pharmaceuticals Ag | Cdk inhibitors |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
US5086186A (en) * | 1989-05-25 | 1992-02-04 | Pfizer Inc. | N-trichloroacetyl-2-oxindole-1-carboxamides |
US5206261A (en) * | 1989-07-25 | 1993-04-27 | Taiho Pharmaceutical Company, Limited | Oxindole derivative |
WO1991009598A1 (en) * | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Azaoxindole derivatives |
GB9004483D0 (en) * | 1990-02-28 | 1990-04-25 | Erba Carlo Spa | New aryl-and heteroarylethenylene derivatives and process for their preparation |
WO1992007830A2 (en) * | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
GB9115160D0 (en) * | 1991-07-12 | 1991-08-28 | Erba Carlo Spa | Methylen-oxindole derivatives and process for their preparation |
US5322950A (en) * | 1991-12-05 | 1994-06-21 | Warner-Lambert Company | Imidazole with angiotensin II antagonist properties |
FR2694004B1 (fr) * | 1992-07-21 | 1994-08-26 | Adir | Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent. |
GB9226855D0 (en) * | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
GB9313638D0 (en) * | 1993-07-01 | 1993-08-18 | Erba Carlo Spa | Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
GB9326136D0 (en) * | 1993-12-22 | 1994-02-23 | Erba Carlo Spa | Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
GB9412719D0 (en) * | 1994-06-24 | 1994-08-17 | Erba Carlo Spa | Substituted azaindolylidene compounds and process for their preparation |
GB9423997D0 (en) * | 1994-11-28 | 1995-01-11 | Erba Carlo Spa | Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
GB9501567D0 (en) * | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
GB9507298D0 (en) * | 1995-04-07 | 1995-05-31 | Pharmacia Spa | Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors |
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
EP0850055B1 (en) * | 1995-09-11 | 2005-06-29 | Osteoarthritis Sciences, Inc. | Protein tyrosine kinase inhibitors for treating osteoarthritis |
US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
GB9610964D0 (en) * | 1996-05-24 | 1996-07-31 | Pharmacia & Upjohn Spa | Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors |
GB9611797D0 (en) * | 1996-06-06 | 1996-08-07 | Pharmacia Spa | Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors |
ES2251741T3 (es) * | 1996-08-23 | 2006-05-01 | Sugen, Inc. | Bibliotecas combinatorias de indolinona y productos afines y metodos para el tratamiento de enfermedades. |
WO1998024432A2 (en) * | 1996-12-05 | 1998-06-11 | Sugen, Inc. | Use of indolinone compounds as modulators of protein kinases |
ATE292623T1 (de) * | 1997-05-07 | 2005-04-15 | Sugen Inc | 2-indolinonderivate als modulatoren der proteinkinase-ativität |
GB9716557D0 (en) * | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
AU3363599A (en) * | 1998-03-26 | 1999-10-18 | Max-Planck Institut Fur Biochemie | Heterocyclic families of compounds for the modulation of tyrosine protein kinase |
US6395734B1 (en) * | 1998-05-29 | 2002-05-28 | Sugen, Inc. | Pyrrole substituted 2-indolinone protein kinase inhibitors |
JP2002522452A (ja) * | 1998-08-04 | 2002-07-23 | スージェン・インコーポレーテッド | 蛋白質キナーゼの調節剤3−メチリデニル−2−インドリノン |
CA2342222A1 (en) * | 1998-08-31 | 2000-03-09 | Sugen, Inc. | Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
CN1138773C (zh) * | 1998-12-17 | 2004-02-18 | 霍夫曼-拉罗奇有限公司 | 4-链烯基(和炔基)氧吲哚作为细胞周期蛋白-依赖性激酶尤其是cdk2的抑制剂 |
-
1999
- 1999-12-08 CN CNB998145246A patent/CN1138773C/zh not_active Expired - Fee Related
- 1999-12-08 DK DK99963422T patent/DK1157019T3/da active
- 1999-12-08 EP EP99963422A patent/EP1157019B1/en not_active Expired - Lifetime
- 1999-12-08 AU AU19727/00A patent/AU770375B2/en not_active Ceased
- 1999-12-08 ES ES99963422T patent/ES2192877T3/es not_active Expired - Lifetime
- 1999-12-08 JP JP2000588168A patent/JP2002532492A/ja active Pending
- 1999-12-08 BR BR9916327-6A patent/BR9916327A/pt not_active Application Discontinuation
- 1999-12-08 TR TR2001/01860T patent/TR200101860T2/xx unknown
- 1999-12-08 PT PT99963422T patent/PT1157019E/pt unknown
- 1999-12-08 KR KR1020017007610A patent/KR100649925B1/ko not_active IP Right Cessation
- 1999-12-08 CA CA002354873A patent/CA2354873A1/en not_active Abandoned
- 1999-12-08 WO PCT/EP1999/009624 patent/WO2000035908A1/en active IP Right Grant
- 1999-12-08 AT AT99963422T patent/ATE234830T1/de not_active IP Right Cessation
- 1999-12-08 DE DE69906152T patent/DE69906152T2/de not_active Expired - Fee Related
- 1999-12-14 CO CO99078069A patent/CO5261600A1/es not_active Application Discontinuation
- 1999-12-14 PE PE1999001251A patent/PE20001537A1/es not_active Application Discontinuation
- 1999-12-15 AR ARP990106414A patent/AR024847A1/es not_active Application Discontinuation
- 1999-12-15 US US09/464,502 patent/US6130239A/en not_active Expired - Fee Related
- 1999-12-16 UY UY25857A patent/UY25857A1/es not_active Application Discontinuation
- 1999-12-16 TW TW088122068A patent/TW550262B/zh active
-
2000
- 2000-04-14 US US09/549,864 patent/US6252086B1/en not_active Expired - Fee Related
- 2000-05-05 US US09/566,054 patent/US6303793B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1138773C (zh) | 2004-02-18 |
CO5261600A1 (es) | 2003-03-31 |
AR024847A1 (es) | 2002-10-30 |
ES2192877T3 (es) | 2003-10-16 |
DK1157019T3 (da) | 2003-07-14 |
DE69906152D1 (de) | 2003-04-24 |
CA2354873A1 (en) | 2000-06-22 |
BR9916327A (pt) | 2001-09-18 |
CN1330647A (zh) | 2002-01-09 |
AU770375B2 (en) | 2004-02-19 |
JP2002532492A (ja) | 2002-10-02 |
TR200101860T2 (tr) | 2001-12-21 |
US6303793B1 (en) | 2001-10-16 |
AU1972700A (en) | 2000-07-03 |
EP1157019B1 (en) | 2003-03-19 |
TW550262B (en) | 2003-09-01 |
WO2000035908A1 (en) | 2000-06-22 |
ATE234830T1 (de) | 2003-04-15 |
UY25857A1 (es) | 2001-07-31 |
DE69906152T2 (de) | 2004-02-12 |
PE20001537A1 (es) | 2001-01-09 |
US6252086B1 (en) | 2001-06-26 |
US6130239A (en) | 2000-10-10 |
KR20010101274A (ko) | 2001-11-14 |
KR100649925B1 (ko) | 2007-02-28 |
EP1157019A1 (en) | 2001-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1157019E (pt) | 4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2 | |
NO20005151D0 (no) | Substituerte indoliner med en inhiberende effekt pÕ kinaser og cyclin/CDK komplekser | |
PT1268480E (pt) | Derivados de 8-quinolinil-xantina e 8-isoquinolinil-xantina como inibidores da pde 5 | |
ATE306487T1 (de) | Purinhemmer von cyclinabhängiger kinase 2 und ikb-alpha | |
PL347884A1 (en) | Substituted benzimidazoles and their use as parp inhibitors | |
NO20015045D0 (no) | Diaminotiazoler og deres anvendelse til inhibering av proteinkinaser | |
PT1144403E (pt) | Pirazoles substituidos como inibidores de p38 quinase | |
NO20031238D0 (no) | Xantin-fosfodiesterase V-inhibitorer | |
NO20022864D0 (no) | Aminotiazol inhibitorer av cyclin avhengige kinaser | |
NO20022656L (no) | Caspaseinhibitorer og anvendelse derav | |
IL145764A0 (en) | Pyrazolobenzodiazepines as cdk2 inhibitors | |
EP1490373A4 (en) | INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND NUCLEOSIDASES | |
PT1117659E (pt) | Cianoquinolinas substituidas como inibidores de tirosina-quinases de proteinas | |
AU2509602A (en) | Cyclin-dependent kinase (CDK) and glycolene synthase kinase-3 (GSK-3) inhibitors | |
ATE269701T1 (de) | Gyrase-inhibitoren und ihre verwendung | |
AR028575A1 (es) | Derivados de pirrolopiridinona utiles como inhibidores de fosfodiesterasa | |
IS6822A (is) | Imidazól- og bezimidazól kaspasatálmar og notkun þeirra | |
HK1049661A1 (en) | N-Ä5-ÄÄÄ5-alkyl-2-oxazolylÜmethylÜthioÜ-2-thiazolyn carboxamide inhibitors of cyclin dependent kinases. | |
BR9702328A (pt) | Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosina | |
DE50002261D1 (de) | Schrank zur aufnahme elektronischer baugruppen und verteilerkomponenten | |
ID26661A (id) | Lamina untuk penerapan pada aseptor | |
MXPA03006423A (es) | Naftostirilos. | |
PT1077945E (pt) | Isoquinolinas como inibidores de uroquinase | |
HUP0402639A3 (en) | Antitumor combination comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors and its use | |
AU2003270271A1 (en) | Atomic structure of the catalytic domain for use in designing and identifying inhibitors of zap-70 kinase |